MoS2 phase transition-assisted sensitive detection of cholesterol on the Copper oxide@Molybdenum disulfide nanocomposite

Abstract

The development of nonenzymatic cholesterol sensors is essential for overcoming the stability and cost constraints inherent in traditional enzyme-based assays. In this work, we report the synthesis of a CuO@MoS₂ nanocomposite via a combined exfoliation-hydrothermal and sonication approach. This strategy successfully integrates ultrasmall CuO nanoparticles onto the surface of exfoliated MoS₂ nanosheets, creating an optimised interface for rapid charge transfer. Structural and electrochemical analysis reveals that cholesterol oxidation triggers a decisive partial phase transition in MoS₂, shifting it from the semiconducting 2H phase to the highly conductive metallic 1T phase. This in situ transformation significantly enhances electron mobility and catalytic kinetics, resulting in excellent sensing performance. The sensor demonstrates high sensitivity, a remarkably low limit of detection of 26.25 x 10-4 mg dL⁻¹ and excellent selectivity against common interferents in complex biological fluids. The sensor is successfully validated using whole blood and human serum samples, even at high concentrations. The synergistic effects of high-surface-area nanosheets and electrochemically induced phase modulation make this CuO@MoS₂ sensor platform a robust and scalable solution for next-generation clinical assays and point-of-care diagnostic devices. on, this material exhibited a polycrystalline structure and demonstrated enhanced performance due to the synergistic effects of its components. Cholesterol oxidation was significantly enhanced by the peroxidase-like properties of MoS₂ combined with the strong catalytic effect of CuO, resulting in a decisive transition of MoS₂ from the semiconducting 2H phase to the metallic 1T phase. The sensor detected up to 400 mg/dL of total cholesterol in whole blood, making it suitable for measuring cholesterol in whole blood.